Characteristics of gastrointestinal stromal tumors in a Middle Eastern population

Saudi Medical Journal

Volumn 31, Issue 7, 2010, Pages 797-802

  Barakat, Fareed H ^a   Haddad, Hussam A ^a   Matalka, Ismail I ^b   Al Orjani, Mohammed S ^b   Al Masri, Mahmoud M ^b   Sughayer, Maher A ^a  

^a Departments of Pathology   (Jordan)

^b KING ABDULLAH UNIVERSITY HOSPITAL   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ABDOMINAL TUMOR; ARTICLE; CANCER RISK; COLON TUMOR; FEMALE; GALLBLADDER TUMOR; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE TUMOR; INTRAABDOMINAL MESENCHYMAL TUMOR; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; PELVIS TUMOR; RETROPERITONEAL TUMOR; SEX DIFFERENCE; STOMACH TUMOR; ADOLESCENT; ADULT; AGED; CHILD; INFANT; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; MIDDLE EAST; YOUNG ADULT;

EID: 77958456923     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-1220.
2. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000; 24: 211-222.
3. Rossi G, Valli R, Bertolini F, Marchioni A, Cavazza A, Mucciarini C, et al. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology 2005; 46: 522-531.
4. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002; 33: 459-465.
5. DeMatteo RP. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Oncol 2002; 9: 831-839.
6. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83.
7. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000; 24: 1339-1352.
8. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999; 154: 53-60.
9. Rauf F, Bhurgri Y, Pervez S. Gastrointestinal stromal tumors: a demographic, morphologic and immunohistochemical study. Indian J Gastroenterol 2007; 26: 214-216.
10. Lee JL, Ryu MH, Chang HM, Kim TW, Kang HJ, Sohn HJ, et al. Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response. Jpn J Clin Oncol 2006; 36: 704-711.
11. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006; 130: 1466-1478.
12. Orosz Z, Tornóczky T, Sápi Z. Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases. Pathol Oncol Res 2005; 11: 11-21.
13. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004; 22: 3813-3825.
14. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, et al. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999; 59: 4297-4300.